» Articles » PMID: 26844206

Incretin-like Effects of Small Molecule Trace Amine-associated Receptor 1 Agonists

Abstract

Objective: Type 2 diabetes and obesity are emerging pandemics in the 21st century creating worldwide urgency for the development of novel and safe therapies. We investigated trace amine-associated receptor 1 (TAAR1) as a novel target contributing to the control of glucose homeostasis and body weight.

Methods: We investigated the peripheral human tissue distribution of TAAR1 by immunohistochemistry and tested the effect of a small molecule TAAR1 agonist on insulin secretion in vitro using INS1E cells and human islets and on glucose tolerance in C57Bl6, and db/db mice. Body weight effects were investigated in obese DIO mice.

Results: TAAR1 activation by a selective small molecule agonist increased glucose-dependent insulin secretion in INS1E cells and human islets and elevated plasma PYY and GLP-1 levels in mice. In diabetic db/db mice, the TAAR1 agonist normalized glucose excursion during an oral glucose tolerance test. Sub-chronic treatment of diet-induced obese (DIO) mice with the TAAR1 agonist resulted in reduced food intake and body weight. Furthermore insulin sensitivity was improved and plasma triglyceride levels and liver triglyceride content were lower than in controls.

Conclusions: We have identified TAAR1 as a novel integrator of metabolic control, which acts on gastrointestinal and pancreatic islet hormone secretion. Thus TAAR1 qualifies as a novel and promising target for the treatment of type 2 diabetes and obesity.

Citing Articles

Genome-Wide Identification, Characterization of the (Olfactory Receptor Class A) Gene Family, and Potential Roles in Bile Acid and Pheromone Recognition in Mandarin Fish ().

Dong X, Lv M, Zeng M, Chen X, Wang J, Liang X Cells. 2025; 14(3).

PMID: 39936981 PMC: 11817882. DOI: 10.3390/cells14030189.


Functional Analysis of TAAR1 Expression in the Intestine Wall and the Effect of Its Gene Knockout on the Gut Microbiota in Mice.

Vaganova A, Zhukov I, Shemiakova T, Rozhkov K, Alferova L, Karaseva A Int J Mol Sci. 2024; 25(23).

PMID: 39684925 PMC: 11642329. DOI: 10.3390/ijms252313216.


Thyroid Hormone Biomonitoring: A Review on Their Metabolism and Machine-Learning Based Analysis on Effects of Endocrine Disrupting Chemicals.

Chen S, Yu M, Yao Y, Li Y, He A, Zhou Z Environ Health (Wash). 2024; 2(6):350-372.

PMID: 39473465 PMC: 11503987. DOI: 10.1021/envhealth.3c00184.


Dopamine Receptors and TAAR1 Functional Interaction Patterns in the Duodenum Are Impaired in Gastrointestinal Disorders.

Vaganova A, Markina A, Belousov A, Lenskaia K, Gainetdinov R Biomedicines. 2024; 12(7).

PMID: 39062162 PMC: 11274761. DOI: 10.3390/biomedicines12071590.


Trace amine associated receptor 1: predicted effects of single nucleotide variants on structure-function in geographically diverse populations.

Shajan B, Marri S, Bastiampillai T, Gregory K, Hellyer S, Nair P Hum Genomics. 2024; 18(1):61.

PMID: 38863077 PMC: 11165750. DOI: 10.1186/s40246-024-00620-w.


References
1.
Scrocchi L, Brown T, MacLusky N, Brubaker P, AUERBACH A, Joyner A . Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996; 2(11):1254-8. DOI: 10.1038/nm1196-1254. View

2.
Dinter J, Muhlhaus J, Jacobi S, Wienchol C, Coster M, Meister J . 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling. J Mol Endocrinol. 2015; 54(3):205-16. DOI: 10.1530/JME-15-0003. View

3.
Bunzow J, Sonders M, Arttamangkul S, Harrison L, Zhang G, Quigley D . Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol. 2001; 60(6):1181-8. DOI: 10.1124/mol.60.6.1181. View

4.
Wynne K, Bloom S . The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Nat Clin Pract Endocrinol Metab. 2006; 2(11):612-20. DOI: 10.1038/ncpendmet0318. View

5.
Nauck M, Niedereichholz U, Ettler R, Holst J, Orskov C, Ritzel R . Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997; 273(5):E981-8. DOI: 10.1152/ajpendo.1997.273.5.E981. View